BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32417377)

  • 21. Right ventricular free wall longitudinal strain and stroke work index for predicting right heart failure after left ventricular assist device therapy.
    Gumus F; Durdu MS; Cakici M; Kurklu TST; Inan MB; Dincer I; Sirlak M; Akar AR
    Interact Cardiovasc Thorac Surg; 2019 May; 28(5):674-682. PubMed ID: 30561630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
    Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE
    Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in renal function after implantation of continuous-flow left ventricular assist devices.
    Hasin T; Topilsky Y; Schirger JA; Li Z; Zhao Y; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Joyce L; Daly R; Park SJ; Kushwaha SS
    J Am Coll Cardiol; 2012 Jan; 59(1):26-36. PubMed ID: 22192665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes After Continuous-Flow Left Ventricular Assist Device Implantation as Destination Therapy at Transplant Versus Nontransplant Centers.
    Brinkley DM; DeNofrio D; Ruthazer R; Vest AR; Kapur NK; Couper GS; Kiernan MS
    Circ Heart Fail; 2018 Mar; 11(3):e004384. PubMed ID: 29540471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age and gender differences and factors related to change in health-related quality of life from before to 6 months after left ventricular assist device implantation: Findings from Interagency Registry for Mechanically Assisted Circulatory Support.
    Grady KL; Sherri Wissman ; Naftel DC; Myers S; Gelijins A; Moskowitz A; Pagani FD; Young JB; Spertus JA; Kirklin JK
    J Heart Lung Transplant; 2016 Jun; 35(6):777-88. PubMed ID: 27068037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry.
    Schmitto JD; Shaw S; Garbade J; Gustafsson F; Morshuis M; Zimpfer D; Lavee J; Pya Y; Berchtold-Herz M; Wang A; Gazzola C; Potapov E; Saeed D
    Eur Heart J; 2024 Feb; 45(8):613-625. PubMed ID: 38036414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis.
    Shah P; Birk S; Maltais S; Stulak J; Elmi A; Pagani FD; Cowger JA
    J Heart Lung Transplant; 2017 Jun; 36(6):640-649. PubMed ID: 28087105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients.
    Cowger JA; Naka Y; Aaronson KD; Horstmanshof D; Gulati S; Rinde-Hoffman D; Pinney S; Adatya S; Farrar DJ; Jorde UP;
    J Heart Lung Transplant; 2018 Jan; 37(1):15-24. PubMed ID: 29153637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Right ventricular function and residual mitral regurgitation after left ventricular assist device implantation determines the incidence of right heart failure.
    Tang PC; Haft JW; Romano MA; Bitar A; Hasan R; Palardy M; Wu X; Aaronson KD; Pagani FD
    J Thorac Cardiovasc Surg; 2020 Mar; 159(3):897-905.e4. PubMed ID: 31101350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study.
    Netuka I; Sood P; Pya Y; Zimpfer D; Krabatsch T; Garbade J; Rao V; Morshuis M; Marasco S; Beyersdorf F; Damme L; Schmitto JD
    J Am Coll Cardiol; 2015 Dec; 66(23):2579-2589. PubMed ID: 26670056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry.
    Garbade J; Gustafsson F; Shaw S; Lavee J; Saeed D; Pya Y; Krabatsch T; Schmitto JD; Morshuis M; Chuang J; Zimpfer D
    Ann Thorac Surg; 2019 Jan; 107(1):33-39. PubMed ID: 30291831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Less invasive left ventricular assist device implantation may reduce right ventricular failure.
    Pasrija C; Sawan MA; Sorensen E; Voorhees H; Shah A; Strauss E; Ton VK; DiChiacchio L; Kaczorowski DJ; Griffith BP; Pham SM; Kon ZN
    Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):592-598. PubMed ID: 31326991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary Arterial Elastance and INTERMACS-Defined Right Heart Failure Following Left Ventricular Assist Device.
    Muslem R; Ong CS; Tomashitis B; Schultz J; Ramu B; Craig ML; Van Bakel AB; Gilotra NA; Sharma K; Hsu S; Whitman GJ; Leary PJ; Cogswell R; Lozonschi L; Houston BA; Zijlstra F; Caliskan K; Bogers AJJC; Tedford RJ
    Circ Heart Fail; 2019 Aug; 12(8):e005923. PubMed ID: 31401840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Outcomes After Left Ventricular Assist Device Implantation in Older Adults: An INTERMACS Analysis.
    Caraballo C; DeFilippis EM; Nakagawa S; Ravindra NG; Miller PE; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Mullan C; Ali A; Maurer MS; Desai NR; Ahmad T; Topkara VK
    JACC Heart Fail; 2019 Dec; 7(12):1069-1078. PubMed ID: 31779930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: An analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).
    VanderPluym CJ; Cedars A; Eghtesady P; Maxwell BG; Gelow JM; Burchill LJ; Maltais S; Koehl DA; Cantor RS; Blume ED
    J Heart Lung Transplant; 2018 Jan; 37(1):89-99. PubMed ID: 28365175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study.
    Ferreira JP; Metra M; Anker SD; Dickstein K; Lang CC; Ng L; Samani NJ; Cleland JG; van Veldhuisen DJ; Voors AA; Zannad F
    Eur J Heart Fail; 2019 Feb; 21(2):218-226. PubMed ID: 30600578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device.
    Yoruk A; Sherazi S; Massey HT; Kutyifa V; McNitt S; Hallinan W; Huang DT; Chen L; Aktas MK
    Heart Rhythm; 2016 May; 13(5):1052-1056. PubMed ID: 26829113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel percutaneous dual-lumen cannula-based right ventricular assist device provides effective support for refractory right ventricular failure after left ventricular assist device implantation.
    Salna M; Garan AR; Kirtane AJ; Karmpaliotis D; Green P; Takayama H; Sanchez J; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
    Interact Cardiovasc Thorac Surg; 2020 Apr; 30(4):499-506. PubMed ID: 31986207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.